THYROID DYSFUNCTION ASSOCIATED WITH ANTIARRHYTHMIC THERAPY IN PATIENTS FROM IODINE-DEFICIENT REGIONS OF THE ARAL SEA AREA

dc.contributor.author	T.Sh. Abdikadirova., A.V. Alieva., R.H. Trigulova., H.K. Nasirova
dc.date.accessioned	2026-09-16T11:46:57Z
dc.date.available	2026-09-16T11:46:57Z
dc.date.issued	2026-05-11
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/5216
dc.description.abstract	The use of amiodarone in the treatment of cardiac arrhythmias is associated with a significant risk of thyroid dysfunction, particularly in patients living in iodine- deficient regions [1,2,6]. Excess iodine load, combined with compensatory instability of the thyroid gland, may lead to the development of thyrotoxicosis [1,5,6], which adversely affects the course of cardiovascular diseases and worsens prognosis.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Germaniya (INTERNATIONAL CONFERENCE ON HEALTH & TECHNOLOGY) journal	en_US
dc.subject	amiodarone, thyroid dysfunction, thyrotoxicosis, heart rate variability, iodine deficiency, arrhythmias	en_US
dc.title	THYROID DYSFUNCTION ASSOCIATED WITH ANTIARRHYTHMIC THERAPY IN PATIENTS FROM IODINE-DEFICIENT REGIONS OF THE ARAL SEA AREA	en_US
dc.type	Article	en_US